Stocktoria
PETMED EXPRESS INC PETS
Nasdaq · XNAS · stock · Retail-Drug Stores and Proprietary Stores · website · IPO 2000-04-06
PETMED EXPRESS INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Gross margin | 28.1% | 30.5% | 30.2% | 29.8% | 28.3% |
| Operating margin | -32.8% | -0.7% | -2.9% | 2.4% | 8.9% |
| Net margin | -32.0% | -2.8% | -2.7% | 2.0% | 6.9% |
| FCF margin | -18.4% | -0.2% | -0.1% | 8.8% | 6.2% |
| Return on assets | -70.6% | -4.2% | -4.4% | 3.1% | 10.6% |
| Return on equity | -197.9% | -7.4% | -7.7% | 4.7% | 15.2% |
| Current ratio | 0.84 | 1.26 | 1.30 | 2.27 | 4.55 |
| Revenue growth | -21.1% | -19.2% | 9.5% | -5.8% | -11.9% |
Source: SEC EDGAR filings · CIK 0001040130 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.